1. Varney, Melinda E, Niederkorn, Madeline, Konno, Hiroyasu, Inoue, Jun-ichiro, Starczynowski, Daniel T. 2015. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling. In The Journal of experimental medicine, 212, 1967-85. doi:10.1084/jem.20141898. https://pubmed.ncbi.nlm.nih.gov/26458771/
2. Kwon, Young-Chang, Kim, Jae-Jung, Yu, Jeong Jin, Jang, Gi Young, Lee, Jong-Keuk. 2018. Identification of the TIFAB Gene as a Susceptibility Locus for Coronary Artery Aneurysm in Patients with Kawasaki Disease. In Pediatric cardiology, 40, 483-488. doi:10.1007/s00246-018-1992-7. https://pubmed.ncbi.nlm.nih.gov/30267110/
3. Niederkorn, Madeline, Hueneman, Kathleen, Choi, Kwangmin, Meetei, Ruhikanta, Starczynowski, Daniel T. . TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis. In Cell reports, 30, 2776-2790.e6. doi:10.1016/j.celrep.2020.01.093. https://pubmed.ncbi.nlm.nih.gov/32101751/
4. Zhao, Jinming, Xiu, Yan, Fu, Lin, Boyce, Brendan F, Zhao, Chen. 2021. TIFAB accelerates MLL-AF9-Induced acute myeloid leukemia through upregulation of HOXA9. In iScience, 24, 103425. doi:10.1016/j.isci.2021.103425. https://pubmed.ncbi.nlm.nih.gov/34877491/
5. Wang, Yang, Xiu, Yan, Dong, Qianze, Starczynowski, Daniel T, Zhao, Chen. . TIFAB modulates metabolic pathways in KMT2A::MLLT3-induced AML through HNF4A. In Blood advances, 9, 844-855. doi:10.1182/bloodadvances.2024013446. https://pubmed.ncbi.nlm.nih.gov/39626355/